Serenity Anesthesia Consultants, PLLC – Trademark Portfolio
Entity Type: 99
Serenity Anesthesia Consultants, PLLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SERENITY ANESTHESIA. The owner is based in Manchester, NH.
45 Bay Street
Manchester, NH 03104
Showing of trademarks Trademarks
Trademark Classifications
Serenity Anesthesia Consultants, PLLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Serenity Anesthesia Consultants, PLLC have?
Serenity Anesthesia Consultants, PLLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Serenity Anesthesia Consultants, PLLC file in?
Serenity Anesthesia Consultants, PLLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Serenity Anesthesia Consultants, PLLC's most well-known trademarks?
Serenity Anesthesia Consultants, PLLC's registered trademark portfolio includes well-known marks such as SERENITY ANESTHESIA. These are among 2 currently registered trademarks in the portfolio.
What is Serenity Anesthesia Consultants, PLLC's trademark registration success rate?
Serenity Anesthesia Consultants, PLLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.